Posts tagged drug

Consortium Backs Netherton Syndrome Project From Sinai Health

Toronto Innovation Acceleration Partners (TIAP), Evotec SE and AmorChem II Fund L.P. (AmorChem) are pleased to announce a $1.75M investment into a drug development project focused on a rare skin disease called Netherton Syndrome, that affects one in 200,000 newborns worldwide.

NewsGuest UserMay 14, 2020investment, drug, Amorchem

The evolution of immuno-oncology is so rapid that the research stage is already outdated!

Immuno-oncology has become increasingly prominent in the medical research industry.

NewsCatherine LamontagneMarch 20, 2017immuno-oncology, research, development, ICSD, Kephren, clinic, Georges Pompidou, drug